z-logo
Premium
Bifunctional Magnetic Luminescent Particles Based on Iron Oxide Nanoparticles Grafted with a Europium Silylated Bypiridine Tris(β‐diketonate) Complex
Author(s) -
Silva Robson R.,
Duarte Adriana P.,
Sábio Rafael M.,
Caiut José M. A.,
Gressier Marie,
Menu MarieJoëlle,
Franco Adolfo,
Ribeiro Sidney J. L.
Publication year - 2016
Publication title -
chemistryselect
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.437
H-Index - 34
ISSN - 2365-6549
DOI - 10.1002/slct.201601203
Subject(s) - europium , nanocomposite , luminescence , materials science , superparamagnetism , bifunctional , nanoparticle , photochemistry , chemical engineering , nanotechnology , chemistry , organic chemistry , magnetization , physics , optoelectronics , quantum mechanics , magnetic field , engineering , catalysis
Abstract A new highly magnetic‐luminescent nanocomposites has been synthesized by grafting luminescent europium complex comprising tris(b‐diketone) and bypridine ligand modified with a silylil function group (Eu[(TTA) 3 (Bpy‐Si)] complex) on the surface of superparamagnetic iron oxide nanoparticles with 11 nm in size coated with a thin silica outer layer. The γ‐Fe 2 O 3 /SiO 2 nanoparticles were fully characterized by ATR‐FTIR, FE‐SEM, HR‐TEM and magnetic measurements to confirm the structure of nanocomposite and the superparamagnetic behavior. Grafting with europium silylated bypiridine tris(β‐diketonate) complex on nanoparticles surface was achieved by covalent bonding through triethoxysilyl groups which allows high concentration of the luminescent species. The resulting nanocomposite display superparamagnetic profile and the indirect excitation in the ultraviolet region outcomes high red luminescence intensity (at 613 nm) with narrow characteristic emission lines of Eu(III) and emission lifetime in the millisecond range. The nanocomposite is potentially useful for applications as biolabelling, imaging, bio‐separation and bioassays.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here